Biothera, Inc. (Biothera)

Oncology Corporate Profile

HQ Location

3388 Mike Collins Drive
Eagan, MN 55121

Company Description

Biothera is a biotechnology company dedicated to improving immune health. The Company is developing a natural gluco polysaccharide that engages and directs natural innate immune system responses. Biothera is developing a drug (Imprime PGG®) to work synergistically with anti-tumor monoclonal antibodies against colon, lung and other cancers.

Website: http://www.biothera.com

This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
Imprime PGG® (+ cetuximab)immunomodulator2nd line metastatic Colorectal cancerIII
Imprime PGG® (+ cetuximab)immunomodulator3rd line metastatic Colorectal cancerIII
Imprime PGG® (+ bevacizumab and carboplatin and paclitaxel)immunomodulator1st line metastatic Non Small cell Lung Cancer (NSCLC)II
Imprime PGG® (+ cetuximab and carboplatin and paclitaxel)immunomodulator1st line metastatic Non Small cell Lung Cancer (NSCLC)II
Imprime PGG® (+ cetuximab and irinotecan)immunomodulator2nd line metastatic Colorectal cancerII
Imprime PGG® (+ cetuximab and irinotecan)immunomodulator3rd line metastatic Colorectal cancerII
Imprime PGG® (+ cetuximab)immunomodulator1st line metastatic Colorectal cancerII
Imprime PGG® (+ pembrolizumab)immunomodulator2nd line metastatic MelanomaIIMerck
Imprime PGG® (+ pembrolizumab)immunomodulator2nd line Squamous cell cancer of the head and neck (SCCHN)IIMerck
Imprime PGG® (+ pembrolizumab)immunomodulator3rd line Squamous cell cancer of the head and neck (SCCHN)IIMerck
Imprime PGG® (+ pembrolizumab)immunomodulatorTriple negative Breast cancerIIMerck
Imprime PGG® (+ rituximab and alemtuzumab)immunomodulator1st line high risk Chronic Lymphocytic Leukemia (CLL)II
Imprime PGG® (+ bevacizumab)immunomodulator2nd line metastatic MelanomaI
Imprime PGG® (+ bevacizumab)immunomodulator3rd line metastatic MelanomaI
Imprime PGG® (+ pembrolizumab)immunomodulatorNon Small Cell Lung Cancer (NSCLC)IMerck

View additional information on product candidates here »

Source: http://www.biothera.com

Recent News Headlines

There are no news items to display